| Terminated | A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delaf Healthy | Phase 1 | 2024-06-03 |
| Completed | Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients Acute Bacterial Skin and Skin Structure Infection | Phase 1 | 2019-07-16 |
| Withdrawn | A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ven Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia, Hospital-Acquired Pneumonia | Phase 3 | 2018-08-01 |
| Completed | Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Heal Pneumonia | Phase 1 | 2018-04-30 |
| Completed | A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Gram-Positive Bacterial Infections | — | 2017-04-12 |
| Completed | Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pn Community Acquired Bacterial Pneumonia | Phase 3 | 2016-12-14 |
| Terminated | Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia Community-acquired Bacterial Pneumonia | Phase 2 / Phase 3 | 2016-04-01 |
| Completed | Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis Nonalcoholic Steatohepatitis | Phase 2 | 2015-12-01 |
| Completed | Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects VA Drug Interactions | Phase 1 | 2015-06-01 |
| Completed | Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects Healthy | Phase 1 | 2015-06-01 |
| Completed | Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects Healthy | Phase 1 | 2015-04-01 |
| Completed | Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers Healthy Volunteers | Phase 1 | 2015-01-01 |
| Completed | Pharmacokinetics and Safety of Solithromycin in Adolescents and Children Bacterial Infection | Phase 1 | 2015-01-01 |
| Completed | Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Urinary Tract Infection Complicated, Acute Pyelonephritis | Phase 3 | 2014-11-20 |
| Completed | Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment Hepatic Impairment | Phase 1 | 2014-09-01 |
| Completed | Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin i Uncomplicated Urogenital Gonorrhea | Phase 3 | 2014-08-01 |
| Completed | Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infectio Skin and Subcutaneous Tissue Bacterial Infections, Skin Structures and Soft Tissue Infections | Phase 3 | 2014-05-01 |
| Terminated | Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea Gonorrhea | Phase 3 | 2014-01-23 |
| Completed | Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents Bacterial Infections | Phase 1 | 2013-12-01 |
| Completed | Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxif Community-acquired Bacterial Pneumonia | Phase 3 | 2013-11-01 |
| Completed | Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infe Skin and Subcutaneous Tissue Bacterial Infections | Phase 3 | 2013-04-01 |
| Completed | Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunte Healthy | Phase 1 | 2013-01-01 |
| Completed | A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants Healthy | Phase 1 | 2012-12-27 |
| Completed | Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patien Community-acquired Bacterial Pneumonia | Phase 3 | 2012-12-01 |
| Completed | Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea Uncomplicated Urogenital Gonorrhea | Phase 2 | 2012-05-01 |
| Completed | A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections Skin and Subcutaneous Tissue Bacterial Infections | Phase 2 | 2011-01-01 |
| Completed | Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure In Wound Infection, Abscess, Systemic Inflammation | Phase 3 | 2010-12-01 |
| Completed | Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structur Wound Infection, Abscess, Systemic Inflammation | Phase 3 | 2010-12-01 |
| Completed | Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Communit Community-Acquired Bacterial Pneumonia | Phase 2 | 2010-08-01 |
| Completed | Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections Skin Structure Infections, Bacterial Skin Diseases, Staphylococcal Skin Infections | Phase 2 | 2008-06-01 |
| Completed | Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections Infectious Skin Diseases, Bacterial Skin Diseases, Staphylococcal Skin Infections | Phase 2 | 2007-12-01 |
| Completed | Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia Community-Acquired Pneumonia (CAP) | Phase 2 | 2007-10-01 |